Search results
Eli Lilly's Potential Alzheimer’s Drug Clears a Big Hurdle
Time via Yahoo News· 3 days agoWhile they are at highest risk, they are also most vulnerable to the ARIA side effect, and it’s not...
FDA advisory panel recommends new Alzheimer's drug after scrutiny
United Press International via Yahoo News· 3 days agoA U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the...
FDA Panelists Unanimously Back Eli Lilly's Biogen-Rivaling Alzheimer's Drug
Investor's Business Daily· 4 days agoThey recommended the same outcome for donanemab. Meanwhile, commentary from a 79-year-old man with...
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
Zacks via Yahoo Finance· 11 hours agoThe FDA committee’s endorsement of donanemab, in a way, reflects FDA’s optimistic approach for Aβ...
FDA advisors strongly back new Alzheimer’s drug, despite risks and limitations
WUSF 89.7· 4 days agoAll 11 committee members also recommended that doctors and patients have the option of halting...
A guide to safe US sunscreens – and the ingredients to avoid
The Guardian via Yahoo News· 2 days agoHawaii became the first US state to ban sunscreens containing these chemicals in 2018. What are the...
Advisory Panel of Experts Endorses FDA Approval of New Alzheimer’s Drug
The New York Times via Yahoo News· 4 days agoA committee of independent advisers to the Food and Drug Administration voted unanimously Monday...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 13 hours agoThe latest sNDA was based on data from the phase III LAURA study. Data from the study showed that...
Lilly's donanemab sails through FDA meeting with 2 unanimous votes in favor
FierceBiotech· 4 days agoDo the available data show that donanemab is effective for the treatment of Alzheimer’s disease in...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
Live Science via Yahoo News· 1 day ago"For almost all CAR-T recipients, the potentially life-saving benefit of CAR-T is likely to outweigh...